- Report
- September 2020
- 92 Pages
Global
From €3838EUR$4,000USD£3,319GBP
- Report
- August 2022
- 318 Pages
Global
From €3454EUR$3,600USD£2,987GBP
- Webinar
- October 2019
- 3 Hours
Global
From €326EUR$340USD£282GBP
- Report
- July 2021
- 121 Pages
Global
From €3200EUR$3,573USD£2,864GBP
- Report
- October 2023
- 146 Pages
Global
From €3385EUR$3,528USD£2,927GBP
€3982EUR$4,150USD£3,443GBP
- Report
- April 2024
- 132 Pages
Global
From €912EUR$950USD£788GBP
- Webinar
- 90 Minutes
Global
From €182EUR$190USD£158GBP
- Report
- July 2022
- 358 Pages
Global
From €3684EUR$3,840USD£3,186GBP
The Electronic Trial Master File (ETMF) market is a subset of the drug discovery industry. It is a digital platform that enables pharmaceutical companies to store and manage clinical trial data. It is used to ensure compliance with regulatory requirements and to facilitate the sharing of data between stakeholders. ETMF solutions provide a secure, centralized repository for clinical trial documents, such as protocols, investigator brochures, and informed consent forms. They also enable the tracking of data from multiple sources, such as clinical trial sites, laboratories, and sponsors.
ETMF solutions are designed to streamline the clinical trial process, reduce costs, and improve data accuracy. They also provide a secure environment for the storage and sharing of sensitive data.
Some companies in the ETMF market include Oracle, Veeva Systems, Medidata Solutions, and MasterControl. Show Less Read more
